Meglumine antimoniate: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 23: | Line 23: | ||
''' [[Meglumine antimoniate description|Description]]''' | ''' [[Meglumine antimoniate description|Description]]''' | ||
'''| [[Meglumine antimoniate clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Meglumine antimoniate clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Meglumine antimoniate indications and usage|Indications and Usage]]''' | '''| [[Meglumine antimoniate indications and usage|Indications and Usage]]''' | ||
'''| [[Meglumine antimoniate contraindications|Contraindications]]''' | '''| [[Meglumine antimoniate contraindications|Contraindications]]''' | ||
'''| [[Meglumine antimoniate warnings and precautions|Warnings and Precautions]]''' | '''| [[Meglumine antimoniate warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Meglumine antimoniate adverse reactions|Adverse Reactions]]''' | '''| [[Meglumine antimoniate adverse reactions|Adverse Reactions]]''' | ||
'''| [[Meglumine antimoniate dosage and administration|Dosage and Administration]]''' | '''| [[Meglumine antimoniate dosage and administration|Dosage and Administration]]''' | ||
'''| [[Meglumine antimoniate how supplied|How Supplied]]''' | '''| [[Meglumine antimoniate how supplied|How Supplied]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 03:45, 7 January 2014
| Meglumine Antimoniate |
|---|
| GLUCANTIM® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Meglumine antimonate
Overview
Meglumine antimoniate is a medicine used for treating leishmaniasis. It is manufactured by Aventis and sold as Glucantime in France, and Glucantim in Italy.
It belongs to a group of compounds known as the pentavalent antimonials. It is administered by intramuscular injection.
Category
Antiparasitic
Brand Names
GLUCANTIM®, GLUCANTIME® (NOT AVAILABLE)
WHO Model Prescribing Information
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied